In a study conducted by Giglio et al., mitoxantrone and doxorubicin, two pro-ICD agents, stimulated the release of high levels of HMGB1 in melanoma cell lines, thus confirming that both agents could induce cell death. Here, HMGB1 is linked to melanoma.